Table 2. The incidence and hazard ratio for cataract and cataract-associated risk factor.
Variable | Event | PY | Rate# | Crude HR(95% CI) | Adjusted HR† (95% CI) |
---|---|---|---|---|---|
HCV infection | |||||
No | 3738 | 273224 | 1.37 | 1.00 | 1.00 |
Yes | 1148 | 61686 | 1.86 | 1.36(1.27, 1.45)*** | 1.23(1.14, 1.32)*** |
Age, year | |||||
≤ 49 | 396 | 181705 | 0.22 | 1.00 | 1.00 |
50–64 | 2686 | 11684 | 2.41 | 11.1(10.0, 12.4)*** | 9.20(8.27, 10.3)*** |
65+ | 1804 | 41520 | 4.34 | 20.2(18.1, 22.6)*** | 14.8(13.2, 16.6)*** |
Sex | |||||
Female | 2653 | 153042 | 1.73 | 1.41(1.34, 1.50)*** | 1.22(1.15, 1.29)*** |
Male | 2233 | 181868 | 1.23 | 1.00 | 1.00 |
Comorbidity | |||||
Cirrhosis | |||||
No | 4728 | 329724 | 1.43 | 1.00 | 1.00 |
Yes | 158 | 5186 | 3.05 | 2.09(1.79, 2.45)*** | 1.09(0.92, 1.29) |
Diabetes | |||||
No | 4079 | 315418 | 1.29 | 1.00 | 1.00 |
Yes | 807 | 19472 | 4.14 | 3.18(2.94, 3.43)*** | 1.41(1.30, 1.52)*** |
Hypertension | |||||
No | 2458 | 258134 | 0.95 | 1.00 | 1.00 |
Yes | 2428 | 76776 | 3.16 | 3.31(3.13, 3.51)*** | 1.13(1.06, 1.21)*** |
Hyperlipidemia | |||||
No | 3341 | 285523 | 1.17 | 1.00 | 1.00 |
Yes | 1545 | 49386 | 3.13 | 2.66(2.51, 2.83)*** | 1.25(1.17, 1.34)*** |
Asthma | |||||
No | 4445 | 320217 | 1.39 | 1.00 | 1.00 |
Yes | 441 | 14693 | 3.00 | 2.14(1.94, 2.37)*** | 1.01(0.91, 1.13) |
COPD | |||||
No | 4125 | 312943 | 1.32 | 1.00 | 1.00 |
Yes | 761 | 21967 | 3.46 | 2.61(2.41, 2.82)*** | 1.12(1.03, 1.22)** |
Coronary artery disease | |||||
No | 3670 | 302987 | 1.21 | 1.00 | 1.00 |
Yes | 1216 | 31923 | 3.81 | 3.13(2.93, 3.34)*** | 0.97(0.87, 1.08) |
Alcohol-related illness | |||||
No | 4486 | 319089 | 1.41 | 1.00 | 1.00 |
Yes | 400 | 15821 | 2.53 | 0.86(0.73, 1.02) | - |
Anxiety | |||||
No | 4743 | 323774 | 1.46 | 1.00 | 1.00 |
Yes | 143 | 11136 | 1.28 | 1.78(1.60, 1.97)*** | 0.97(0.87, 1.08) |
Rate#, incidence rate, per 100 person-years; Crude HR, relative hazard ratio; Adjusted HR†: multivariable analysis including age, average number of clinic visits/per year, and comorbidities of diabetes, hypertension, hyperlipidemia, asthma, COPD, coronary artery disease, and anxiety;
** p < 0.01,
*** p<0.001